STAMFORD, Conn., April 23, 2018 -- Hexcel Corporation (NYSE:HXL) today announced that the Company’s Board of Directors has declared a regular quarterly cash dividend of $0.125 per share on the common stock of Hexcel, payable on May 11, 2018 to stockholders of record as of May 4, 2018.
Hexcel Corporation is a leading advanced composites company. It develops, manufactures and markets lightweight, high-performance structural materials, including carbon fibers, specialty reinforcements, prepregs and other fiber-reinforced matrix materials, honeycomb, adhesives, engineered core and composite structures, used in commercial aerospace, space and defense and industrial applications. Learn more at www.Hexcel.com.
| Contact Information | ||
| Kurt Goddard, Vice President – Investor Relations | ||
| (203) 352-6826 | ||
| [email protected] |


Westpac (ASX: WBC) Q1 Profit Rises 6% as Lending Growth and Treasury Income Strengthen Earnings
Vale Reports $3.8 Billion Q4 Net Loss Amid Nickel Asset Impairment and Samarco Provisions
Xiaomi EV Deliveries Surpass 600,000 Units as SU7 and YU7 Drive Strong Growth
Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems
Treasury Wine Estates Profit Falls 46% as China and U.S. Inventory Reset Weighs on Earnings
OpenAI Hires OpenClaw Creator Peter Steinberger to Advance Next-Generation AI Agents
Michael Kors Marks 45 Years at New York Fashion Week with Fall/Winter Collection Showcase
Paramount Skydance Appoints Rene Augustine as SVP of Global Public Policy Amid Warner Bros Takeover Battle
Valero Energy Expands Venezuelan Crude Imports as U.S. Sanctions Ease
Senators Urge CFIUS Review of UAE Investment in Trump-Linked Crypto Firm World Liberty Financial
Vietnam Approves SpaceX Starlink Satellite Internet Service Amid U.S. Trade Talks
How Marco Pharma International Preserves German Homeopathic Traditions in America
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute
Converse Cuts Corporate Jobs as Nike Restructures to Revive Sales Growth
BlueScope Steel Forecasts Stronger Second-Half Earnings, Shares Rise Above Rejected Buyout Offer
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval 



